VC-backed Aimmune Therapeutics goes public

Brisbane, California-based Aimmune Therapeutics, a biopharmaceutical company focused on treating peanut allergies, has raised $160 million for its IPO after pricing its 10 million shares at $16 per share. The stock began trading Thursday on the NASDAQ under the ticker symbol “AIMT.” BofA Merrill Lynch, Credit Suisse and Piper Jaffray are serving as the lead underwriters. Aimmune’s backers include Longitude Capital, Foresite Capital and Aisling Capital.

111 Views

Wynnchurch promotes four to MD

Wynnchurch Capital has promoted Brian Crumbaugh, Greg Gleason, Neel Mayenkar and Michael Teplitsky to managing director. Prior to joining Wynnchurch, Crumbaugh worked at ShoreView Industries and Piper Jaffray while Gleason was at Houlihan Lokey and Bank of America. Mayenkar’s work background includes positions at Houlihan Lokey and at PricewaterhouseCoopers and Teplitsky’s resume has stints at Lime Rock Partners and at UBS Investment Bank.

VC-backed CoLucid goes public

Durham, North Carolina-based CoLucid Pharmaceuticals, which develops oral lasmiditan that treats migraine headaches, has raised $55 million for its IPO after pricing its 5.5 million shares at $10 per share. The stock began trading Wednesday on the NASDAQ under the ticker symbol “CLCD.” Piper Jaffray & Co. and Stifel are serving as the lead underwriters. CoLucid’s backers include TVM Capital Life Science, Novo Ventures, Auriga Partners, Pappas Ventures, Domain Associates, Care Capital, Triathlon Medical Ventures and Pearl Street Ventures.

140 Views

Catterton invests in Pure Barre

Catterton has made a “significant” investment in fitness studio chain Pure Barre. No financial terms were disclosed. Pure Barre is backed by WJ Partners, which will remain an investor as a result of the transaction. Piper Jaffray & Co and Stephens Inc served as financial advisors to Pure Barre.

246 Views

Kohlberg buys AM Conservation Group

Kohlberg & Company LLC has acquired AM Conservation Group, a Charleston, South Carolina-based provider of energy and water efficiency programs and services. No financial terms were disclosed. Piper Jaffray was financial advisor to AM Conservation Group on the transaction while GE Antares Capital, Fifth Third Bank and Metropolitan Life Insurance Company provided credit financing.

239 Views

High Road Capital exits All Current Electrical Sales

High Road Capital Partners has sold All Current Electrical Sales Inc to EBSCO Industries. No financial terms were disclosed. Piper Jaffray provided advice to All Current on the transaction. All Current is a specialty reseller of electrical components.

VC-backed Inotek Pharmaceuticals unveils IPO

Lexington, Massachusetts-based Inotek Pharmaceuticals Corp, a biopharmaceutical firm focused on developing treatments for glaucoma, has debuted its IPO after pricing its over 6.6 million shares at $6 per share. The stock began trading Wednesday on the NASDAQ under the ticker symbol “ITEK.” Cowen and Company LLC and Piper Jaffray & Co are serving as the lead underwriters. Inoteck’s backers include Devon Park Bioventures, Rho Ventures, Care Capital, Medimmune Ventures, Pitango Venture Capital and Horizon Technology Finance Corp.

215 Views

Altamont buys restaurant chain Cotton Patch

Altamont Capital Partners has acquired Cotton Patch Cafe LLC. No financial terms were disclosed. Piper Jaffray & Co. and Locke Lord LLP advised Cotton Patch on the transaction while Ropes & Gray LLP advised Altamont. Cotton Patch is a restaurant chain with locations in Texas, Oklahoma and New Mexico.

105 Views

VC-backed Entellus Medical sets IPO pricing terms

According to an amended SEC filing, Entellus Medical is planning on selling 4.375 million shares of its IPO at a price range between $15 and $17 per share. BofA Merrill Lynch and Piper Jaffray are serving as lead underwriters. Entellus will list the IPO on the NASDAQ under the ticker symbol “ENTL.” Based in Plymouth, Minnesota , Entellus Media provides treatment solutions for chronic sinusitis. Its backers include Covidien Ventures, SV Life Sciences, Essex Wodlands, Split Rock Partners and Greenspring Associates.

 

292 Views

J.W. Childs invests in Cycle Gear

J.W. Childs Associates has bought a majority stake in Cycle Gear. The seller was Harvest Partners. No financial terms were disclosed. Piper Jaffray and Financo provided financial advice to Cycle Gear on the transaction. Headquartered in Benicia, Calif., Cycle Gear is a provider of motorcycle apparel, parts and accessories.

128 Views

VC-backed Flex Pharma files for IPO

According to an SEC filing, Boston-based Flex Pharma, a biotech firm that focuses on treating muscle cramps, has filed for an IPO. Although the number of shares that will be sold as well as the stock’s pricing terms have yet to be set, the document proposes the IPO’s value to be up to $60 million Jefferies and Piper Jaffray are among those named as lead underwriters. Flex Pharma’s backers include Bessemer Venture Partners and Longwood Fund.

 

164 Views

PE-backed Periscope Holdings acquires BidSync

Periscope Holdings, which is backed by Parthenon Capital, has bought BidSync. No financial terms were disclosed. Stephens was financial advisor to Periscope Holdings on the transaction while Piper Jaffray provided financial advice to BidSync. Headquartered in American Fork, Utah, BidSync is a provider of procurement and bid notification solutions for the public sector.

394 Views

Riverside exits screening company DISA

Riverside has sold DISA Global Solutions. No financial terms were disclosed. Piper Jaffray, Houlihan Lokey, Deloitte and Jones Day served as advisors to Riverside on the transaction. Based in Houston, DISA provides drug and alcohol testing, background screening, occupational medicine screening and U.S. Department of Transportation-related compliance services.

PE HUB Community

Join the 12523 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget